Code | 41042 | ||||||||||
MA number | EU/1/98/066/014 | ||||||||||
Product Form: | cps dur 250x1,5 mg (fľ.HDPE) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Novartis Europharm Limited, Ireland | ||||||||||
Therapeutic Class: | 06 - PSYCHOSTIMULANTIA (NOOTROPNE LIEČ., ANALEPTIKA) | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 60 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application |
MA issued: | 12.05.1998 |
SmPC + PL: | European Medicines Agency's database |
Dokument: | Exelon_TTS_DHPC.pdf |
Dokument: | Exelon_Pacientsky_dennik.pdf |
Safety feature | Yes |
Data update: | 27.01.2022 |